pathological findings of diabetic kidney disease · 12/2/2018 · pathological findings of ....
Post on 03-Aug-2020
0 Views
Preview:
TRANSCRIPT
Pathological findings of
diabetic kidney disease
APSN Continuing Medical Education (CME) Course 2019 in Japan Nagoya Congress Center June 20 (Thu), 20199:45-10:20
Kanazawa Medical University
KENGO FURUICHI
<30
30-44
45-59
60-90
≥90
GFR
(mL/
min
/1.7
3 m
2 )
Albuminuria(mg/g)
A1: <30 A2: 30-300 A3: >300
Stage3
Stage 4
Japanese classification of diabetic nephropathy
Stage2Stage1
*; p<0.05All cause mortality
Cardiovascular eventsKidney events
Wada, Furuichi et al. CEN 2013
N= 4,328Type 2 DM7 years follow up
Event risk in each category
eGFRNormo-albuminuria
Micro-albuminuria
Macro-albuminuria
>90Ref
3.3 11.1
>60 3.0 15.6
>45 0.7 3.4 33.4
>30 1.8 3.1 41.4
<30 6.0 5.8 81.7
eGFRNormo-albuminuria
Micro-albuminuria
Macro-albuminuria
>90Ref
1.0 1.3
>60 1.5 2.1
>45 1.0 1.3 1.9
>30 1.4 1.9 2.4
<30 0.4 0.6 2.0
eGFRNormo-albuminuria
Micro-albuminuria
Macro-albuminuria
>90Ref
1.5 4.4
>60 1.4 1.9
>45 1.6 1.2 4.8
>30 1.2 0.8 4.1
<30 7.6 9.3 5.9
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
* *
Pathological findings of diabetic kidney disease
1. What is DKD
2. Pathological variation of DKD
3. DKD and nephrosclerosis
4. Nonproteinuric DKD
CKD with diabetes
DKD
Furuichi K, et al. Clin Exp Nephrol 2018;22:1046-1051
Kidney disease in patients with diabetes
Diabetic nephropathy
Pathological findings of diabetic kidney disease
1. What is DKD in pathology?
2. Pathological variation of DKD
3. DKD and nephrosclerosis
4. Nonproteinuric DKD
Stage 1 Stage 2 Stage 3 Stage 4 Total# of cases 59 87 338 116 600Gender (% of male) 44.0 59.0 70.0 73.0 67.0 Age (yeas old) 54.6 57.6 57.4 61.0 57.9 Height (cm) 153.9 160.4 162.2 163.2 161.7 Weight (Kg) 51.3 60.1 63.7 66.0 63.1 BMI 22.6 23.4 23.9 24.1 23.7 sysBP (mmHg) 133.7 129.7 147.6 152.3 144.6 diaBP (mmHg) 76.0 74.7 80.1 80.2 78.9 Hb (g/dL) 13.2 13.3 12.0 10.3 12.0 UA (mg/dL) 4.5 6.0 6.7 7.5 6.7 TP (g/dL) 6.8 7.1 6.3 5.8 6.3 Alb (g/dL) 4.4 4.0 3.2 2.8 3.3 BS (mg/dL) 201.6 147.6 149.2 113.1 147.4 HbA1c (%) 8.3 8.1 7.7 6.8 7.6 Tcho (mg/dL) 187.1 197.5 226.0 220.1 217.3 TG (mg/dL) 118.1 177.6 172.2 160.4 166.0 eGFR (mL/min/1.73m2) 72.3 71.8 56.3 20.1 53.1 uAlb (g/gCr) 0.0 0.2 2.2 2.7 1.8
Clinical backgroundBased on Japanese classification of diabetic nephropathy 2014
Pathological findings
Glomerular lesions
Diffuse lesion 0-3Nodular lesion 0,1
Subendothelial space widening 0-3Exudative lesion 0,1Mesangiolysis 0,1
Polar vasculosis 0,1Global glomerular sclerosis %
Segmental glomerular sclerosis %Glomerulomegaly 0,1
Interstitial lesions
IFTA 0-3Interstitial cell infiltration 0-3
Vascular lesions
Hyalinosis 0-3Atherosclerosis 0-3
Pathological findings of diabetic nephropathy and nephrosclerosis
Furuichi K, et al. Nephrol Dial Transplant 2018;22:570-582
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
Pathologica changes of diabetic nephropathy.
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
0%20%40%60%80%
100%
1 2 3 4
Score 3Score 2Score 1Score 0
Furuichi K, et al. Clin Exp Nephrol. 2018;22:570-582
GMeg
Diffuse
SubendW
MesLy
PVasNodular
IFTA
ICell
Hyalin
ArterioExudative
p<0.001 p=0.016
Score 0
Score 1
p=0.014
p=0.009
p<0.001
p<0.001
p=0.342
p=0.160
Glomerular diabetic change in early sategindicated poor prognosis.
p<0.001
Furuichi K, et al. , Nephrol Dial Transplant 2018;22:570-582
Nodular lesion
Exudative lesion
Mesangiolysis
Stage 1
Composit kidney eventsStage 2 Stage 3
Stage 1 Stage 2 Stage 3 Stage 4 TotalHR p HR p HR p HR p HR p
Diffuse >100.00 0.00 2.36 0.40 2.41 0.04 4.32 0.15 2.82 0.00Nodular 24.00 0.03 3.55 0.00 1.75 0.00 1.90 0.01 2.43 0.00 Subendo wide 2.89 0.22 2.54 0.05 1.88 0.00 3.21 0.00 2.77 0.38 Exudative 24.00 0.03 1.95 0.19 2.10 0.00 1.37 0.20 2.77 0.00 MesanLy 24.00 0.03 2.66 0.04 2.00 0.00 1.50 0.09 2.57 0.00 PolaVas 1.25 0.79 1.38 0.50 1.60 0.01 1.40 0.22 1.65 0.00 G Sclerosis 1.59 0.68 1.11 0.82 1.40 0.07 1.07 0.89 1.56 0.24 S Sclerosis 1.14 0.90 2.06 0.13 1.67 0.00 1.59 0.06 1.78 0.22 G Megaly 4.92 0.20 1.53 0.35 1.00 0.98 0.87 0.57 1.27 0.05 IFTA 1.09 0.91 2.11 0.18 2.68 0.00 0.36 0.31 3.41 0.88 Interstitial Cell 1.18 0.84 2.11 0.12 3.08 0.00 2.70 0.17 3.60 0.77 Hyalinosis 0.94 0.94 NA 1.00 1.94 0.09 1.81 0.56 2.41 0.74 Atheroscle 1.28 0.75 2.74 0.18 1.53 0.08 2.18 0.28 2.37 0.47
HR for composite kidney event in each pathological findings
Pathological findings of diabetic kidney disease
1. What is DKD in pathology?
2. Pathological variation of DKD
3. DKD and nephrosclerosis
4. Nonproteinuric DKD
Diabetic nephropathy has higher risk in kidney dysfunction than nephrosclerosis
Furuichi K, et al. Clin Exp Nephrol. 2018;22:1046-1051
Increased risk of diabetes
Nephrosclerosis (n = 184)Diabetic nephropathy (n = 600)
Non-CKD
Nephrosclerosis
Diabetic nephropathy
All cause mortality
Composite kidney event
Nephrosclerosis
Diabetic nephropathy
eGFR
chan
ges
(mL/
min
/1.7
3m2 /y
ear) CKD heat map category
カテゴリー G & Y Ogange Red TotalNS
(n=36)DM
(n=103)NS
(n=57)DM
(n=149)NS
(n=91)DM
(n=348)NS
(n=184)DM
(n=600)Age 53.17 54.17 53.60 56.31 57.62 59.63 55.50 57.87
Gender(Male) 0.61 0.53 0.70 0.60 0.65 0.74 0.66 0.67 BMI 26.05 23.25 26.61 23.22 24.22 24.06 25.31 23.72
Sys BP 142.30 131.27 134.95 141.87 141.65 149.52 139.59 144.60 Dia BP 81.55 75.85 81.58 78.88 86.37 79.80 83.89 78.91
Hb 14.40 13.52 14.31 12.83 13.04 11.22 13.70 11.98 eGFR 77.78 82.02 66.06 73.70 36.99 35.78 53.98 53.14 Alb 4.15 4.25 4.09 3.44 3.90 3.08 4.01 3.25
HbA1c 5.90 8.36 5.79 8.41 5.82 7.09 5.83 7.59 Tcho 234.44 196.08 220.85 218.67 213.64 222.45 220.33 217.25
Hematuria 0.42 0.03 0.58 0.30 0.51 0.41 0.51 0.32
Clinical backgroundDiabetic nephropathy and nephrosclerosis
T-test red p<0.05
Pathological findings
Glomerular lesion
DiffuseNodularSubendo wideExdativeMesanLyPolaVasG SclerosisS SclerosisG Megaly
Interstitial lesionsIFTAInterstitial Cell infiltration
Vascluar HyalinosisAtherosclerosis
Diabetic nephropathy
Nephrosclerosis
Pathological findings of diabetic nephropathy and nephrosclerosis
*
* *
*
Pathological findings of diabetic nephropathy and nephrosclerosis
NephrosclerosisDiabetic nephropathy
IFTA ICell
Hyalin Arterio
CKD heat map category
GFR≥60
45–5930–45<30
<30 30–299 ≥300Albuminuria
CKD heat map category
PLoS One. 2018 17;13:e0190493
eGFR change of nephrosclerosis
Pathological findings of diabetic kidney disease
1. What is DKD in pathology?
2. Pathological variation of DKD
3. DKD and nephrosclerosis
4. Nonproteinuric DKD
n=526 with T2D & eGFR<60 1:2 propensity score matching: age, gender, DM duration, baseline eGFR
Yamanouchi M, et al. Diabetes Care 2019;42:891-902
Non-proteinuric DN and proteinuric DN
Yamanouchi M, et al. Diabetes Care 2019;42:891-902
Kidney out come Mortality
Log-rank test p<0.001Log-rank test p<0.001
Non-proteinuric
Proteinuric
Non-proteinuric
Proteinuric
Non-proteinuric DN is better prognosis than proteinuric DN
Diabetes Care 2019;42:891-902
Diabetic glomerular changes were minor in non-proteinuric DN.
Nephrosclerosis
CKD with diabetes
DKD
Diabetic nephropathy
Furuichi K, et al. Clin Exp Nephrol 2018;22:1046-1051
Kidney disease in patients with diabetes
top related